Rural Access to Physical Therapy for Osteoarthritis Rehabilitation - Pilot (RAPTOR)

Rural Access to Physical Therapy for Osteoarthritis Rehabilitation

This is a pilot study involving a hybrid in-person + telerehabilitation intervention for rural adults with knee osteoarthritis. The primary purpose is to demonstrate feasibility and safety of the RAPTOR program, and the secondary purpose is to estimate clinical effectiveness of the RAPTOR program on participants' pain, function, and quality of life.

Study Overview

• Status: Completed
• Conditions: Osteoarthritis, Knee
• Intervention / Treatment: Other: RAPTOR protocol: hybrid in-person + telehealth physical therapy services

Detailed Description

The purpose of the RAPTOR pilot study is to determine feasibility of a rural telerehabilitation intervention by assessing (1) attendance rate for telerehabilitation visits among participants in the pilot program; (2) participants satisfaction with the program; and (3) participant outcomes regarding pain, function, and quality of life. This pilot study will provide preliminary data to support efforts to obtain external funding for a future randomized trial comparing traditional physical therapy (PT) to the RAPTOR approach.

The primary purpose of the RAPTOR pilot study is to demonstrate feasibility and safety of the RAPTOR program in rural adults with knee osteoarthritis (KOA). The secondary purpose is to estimate clinical effectiveness of the RAPTOR program on participants' pain, function, and health-related quality of life. This will enable the investigators to determine a sample size estimate for a future trial comparing RAPTOR to a traditional face-to-face physical therapy approach in this population.

Specific Aim 1: To assess feasibility of the Rural Access to Physical Therapy for Osteoarthritis Rehabilitation (RAPTOR) program in delivering a hybrid telerehabilitation program to rural people with KOA.

Hypothesis 1: Participants in the RAPTOR program will attend at least 80% of study-related in-person and telerehabilitation visits, and will experience no serious adverse events.

Specific Aim 2: To determine preliminary clinical effectiveness of the RAPTOR program by assessing pain, physical function, and health-related quality of life via patient-reported and performance-based outcomes.

Hypothesis 2: A majority of RAPTOR participants will demonstrate clinically meaningful improvement in patient-reported pain, physical function, and/or health-related quality of life.

• Study Type: Interventional
• Enrollment (Actual): 27
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Pennsylvania
    • Pittsburgh, Pennsylvania, United States, 15219
      • University of Pittsburgh

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 40 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Potential participants who meet all of the following criteria will be included:

• Participant meets American College of Rheumatology criteria for the clinical diagnosis of knee osteoarthritis
• Participant's home address is in a rural (non-core) western Pennsylvania county
• Participant is willing to travel to Centers for Rehab Services - Bedford clinic for two face-to-face sessions with a licensed physical therapist
• Participant has access to high-speed internet and/or LTE wireless service and a device (tablet, computer, or smartphone) to access the telerehabilitation platform
• Participant is aged 40 or over

Potential participants will be excluded if any of the following criteria apply:

• Chronic neurological disorder affecting balance or coordination
• Any other disorder that affects balance or gait
• Two or more falls in the past 12 months, OR sought medical attention for any fall within the past 12 months

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: RAPTOR Physical Therapy Intervention; RAPTOR intervention: hybrid in-person + telehealth physical therapy care for rural-dwelling individuals with knee osteoarthritis

Other: RAPTOR protocol: hybrid in-person + telehealth physical therapy services; All participants will receive the RAPTOR intervention, which includes 2 in-person physical therapy visits and 8 telerehabilitation visits. Participants will attend an initial in-person PT evaluation to meet their provider, receive a hands-on assessment of their impairments and functional limitations, and receive instruction in an initial home exercise program. The remainder of their visits will be completed remotely, using a telerehabilitation platform. At the conclusion of care, the patient will return to the clinic for a follow-up assessment and training on their final home exercise program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Recruitment Target	The investigators' recruitment target is 27 participants, and this outcome will be successful upon enrollment of the 27th participant. This outcome will be used as one component of the overall summary outcome of "feasibility", which is defined as success in all 5 primary outcomes.	Through study completion, which is anticipated to take approximately 1 year.
Visit Attendance (75% or higher)	The percentage of physical therapy visits attended, divided by the number of scheduled visits (10) for each participant. This outcome will be successful if mean visit attendance among all participants is at least 75%. This outcome will be used as one component of the overall summary outcome of "feasibility", which is defined as success in all 5 primary outcomes.	Through study completion, which is anticipated to take approximately 1 year.
Telehealth Usability Questionnaire	The Telehealth Usability Questionnaire (5/7) is a self-reported questionnaire used to assess participant satisfaction with the telehealth services received. It contains 21 items, each rated on a 7-point scale ranging from "strongly disagree" (1 point) to "strongly agree" (7 points). The items are summed to create a total score ranging from 7 - 147 points, with higher numbers indicating greater usability of the telehealth services. This outcome will be successful if the average item rating across all participants is at least 5/7. This outcome will be used as one component of the overall summary outcome of "feasibility", which is defined as success in all 5 primary outcomes.	Measured at post-treatment (last visit, approximately 10 weeks after enrollment)
Study-Related Adverse Events / Serious Adverse Events	This outcome will be successful if there are zero study-related adverse events and serious adverse events among the 27 participants. This outcome will be used as one component of the overall summary outcome of "feasibility", which is defined as success in all 5 primary outcomes.	Through study completion, which is anticipated to take approximately 1 year.
Clinically Important Improvement on ONE Functional Outcome Measure	The final component of the overall primary outcome of feasibility will be met if each participant achieves mean improvement on at least one functional outcome measure that exceeds the minimum clinically important difference. This may occur on a self-reported outcome measure (the KOOS, described below) or a performance-based outcome measure (30-second chair stand test, timed stair climb test, Timed Up and Go test, 40-meter fast-paced walk test, 6-minute walk test). All of these outcome measures are individually considered to be Secondary Outcome Measures and are described below in greater detail.	Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Functional outcome measure: 30-second chair stand test	Measures the number of times the participant can stand up and sit down from a chair in a 30-second period.	Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Functional outcome measure: Timed stair climb test	Measures the number of seconds it takes the participant to climb and descend 1 full flight of standard stairs.	Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Functional outcome measure: Timed Up and Go (TUG)	Measures the number of seconds it takes for the participant to stand up from a chair, walk 3 meters, turn around, walk 3 meters back to the chair, and sit back down in the chair.	Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Functional outcome measure: 40-meter fast-paced walk test	Measures the number of seconds it takes the participant to walk 40 meters at what the participant considers to be a "fast pace".	Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Functional outcome measure: 6-minute walk	Measures the number of meters the participant can walk in 6 minutes at a self-selected pace.	Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)
Functional outcome measure: Change from baseline in KOOS (Knee Injury and Osteoarthritis Outcome Score) to Post-Treatment	The KOOS is a self-reported survey containing five subscales, each of which is considered separately (i.e. there is no "total" KOOS score). The investigators will use three of the KOOS subscales: Pain (Minimum Detectable Change [MDC] 13.4 points for people with KOA), Activities of Daily Living (MDC 15.4 points), and Quality of Life (MDC 21.1 points). Each subscale is measured on a 0-100 scale, with lower scores indicating worse symptoms / worse function.	Baseline (measured at first visit) and post-treatment (measured at last visit, approximately 10 weeks later)

Collaborators and Investigators

• Sponsor: University of Pittsburgh
• Collaborators: University of Pittsburgh Medical Center Rehabilitation Institute
• Investigators: Principal Investigator: Allyn Bove, DPT, PhD, University of Pittsburgh

Study record dates

Study Major Dates

• Study Start (Actual): December 20, 2021
• Primary Completion (Actual): September 30, 2024
• Study Completion (Actual): September 30, 2024

Study Registration Dates

• First Submitted: September 29, 2021
• First Submitted That Met QC Criteria: October 28, 2021
• First Posted (Actual): November 10, 2021

Study Record Updates

• Last Update Posted (Actual): October 4, 2024
• Last Update Submitted That Met QC Criteria: October 2, 2024
• Last Verified: October 1, 2024

More Information

Terms related to this study

• Keywords: osteoarthritis; rehabilitation; knee; physical therapy; arthritis; rural; telerehabilitation; telehealth
• Additional Relevant MeSH Terms: Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Arthritis; Osteoarthritis; Osteoarthritis, Knee
• Other Study ID Numbers: STUDY21050074

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Plan Description: Only fully deidentified data will be made available to other researchers upon request and approval by the investigators and the relevant institutional review board.
• IPD Sharing Time Frame: Data will be made available upon the conclusion of the study for up to seven years upon request.
• IPD Sharing Access Criteria: Requests for data sharing must be agreed to by the investigators and the relevant institutional review board.
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL; SAP; ICF; ANALYTIC_CODE

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No